Eastwood, Australia

Lun-Quan Sun

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 89(Granted Patents)


Location History:

  • Ryde, AU (1998 - 2000)
  • Eastwood, AU (2008 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Lun-Quan Sun: Innovator in Gene Therapy

Introduction

Lun-Quan Sun is a prominent inventor based in Eastwood, Australia. He has made significant contributions to the field of gene therapy, particularly in the area of hematopoietic progenitor cells. With a total of five patents to his name, his work has the potential to impact the treatment and prevention of various diseases, including HIV.

Latest Patents

Lun-Quan Sun's latest patents include a process for the preparation of a composition of genetically modified hematopoietic progenitor cells. This invention describes compositions and methods related to gene therapy, specifically applied to hematopoietic progenitor cells. The methods outlined aim to provide prolonged engraftment of modified hematopoietic cells in human subjects. Another significant patent focuses on methods for genetic modification of hematopoietic progenitor cells, emphasizing ex vivo gene therapy for the treatment or prevention of HIV infection.

Career Highlights

Throughout his career, Lun-Quan Sun has worked with notable companies such as Johnson & Johnson Research Pty Limited and Gene Shears Pty Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to gene therapy.

Collaborations

Lun-Quan Sun has collaborated with several professionals in his field, including Geoffrey Phillip Symonds and Rafael G Amado. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Lun-Quan Sun is a key figure in the field of gene therapy, with a focus on hematopoietic progenitor cells. His innovative patents and collaborations highlight his commitment to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…